When one-third of participants were randomized to take a placebo instead of semaglutide for 48 months, they regained 7 percent of the weight they lost
The liquid should always be clear and colorless
Second, the expanding indications for GLP-1 medications beyond weight loss are changing the eligibility landscape
Stroke : There is a small increased risk of stroke for people taking tamoxifen, particularly those with other risk factors like high blood pressure
Ali Rezaie, Medical Director of Gastroenterology Motility at Cedars-Sinai Medical Center, emphasized the need for context, noting that while the relative risk increases by 33%, the absolute risk remains low at 0.2%
Each option has unique benefits, possible side effects, and ways it supports weight management